FENOFIBRATE\SIMVASTATIN: 20 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
20
Total FAERS Reports
1 (5.0%)
Deaths Reported
8
Hospitalizations
20
As Primary/Secondary Suspect
1
Life-Threatening
4
Disabilities
First Report: 2015 · Latest Report: 20250201
What Are the Most Common FENOFIBRATE\SIMVASTATIN Side Effects?
#1 Most Reported
Myalgia
8 reports (40.0%)
#2 Most Reported
Drug interaction
7 reports (35.0%)
#3 Most Reported
Acute kidney injury
6 reports (30.0%)
All FENOFIBRATE\SIMVASTATIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Myalgia | 8 | 40.0% | 0 | 3 |
| Drug interaction | 7 | 35.0% | 0 | 7 |
| Acute kidney injury | 6 | 30.0% | 0 | 5 |
| Nephrotic syndrome | 5 | 25.0% | 0 | 5 |
Who Reports FENOFIBRATE\SIMVASTATIN Side Effects? Age & Gender Data
Gender: 84.6% female, 15.4% male. Average age: 52.5 years. Most reports from: HR. View detailed demographics →
Is FENOFIBRATE\SIMVASTATIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2015 | 4 | 0 | 0 |
| 2016 | 1 | 1 | 0 |
| 2020 | 4 | 0 | 0 |
| 2021 | 1 | 0 | 0 |
| 2025 | 1 | 0 | 1 |
What Is FENOFIBRATE\SIMVASTATIN Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 9 |
Official FDA Label for FENOFIBRATE\SIMVASTATIN
Official prescribing information from the FDA-approved drug label.